£180

Chikungunya Vaccination

Find a clinic
Book Now

Chikungunya is a mosquito‑borne viral illness that causes fever and severe joint pain; it is usually not life‑threatening but can lead to long‑lasting joint symptoms, making prevention and bite avoidance particularly important.

  • When to get vaccinated: You should aim to get your vaccination 6-8 weeks before travelling.
  • Course: Currently one vaccine only is required
  • Boosters: There is currently no reccomendation for a booster.
  • How it is given: Injection in the upper arm.
  • Side effects: The vaccine can cause mild side effects such as rash, a high temperature, nausea or muscle aches.
  • Children: The chikungunya vaccine can be given to children aged 12 years and over and identified at risk of disease by chikungunya virus by a travel health risk assessment
  • Additional precautions: In addition to getting vaccinated you need to practise mosquito bite avoidance.
  •  Risk if you contract the disease:
    Overall risk level
    Chikungunya is rarely fatal
    Most people recover fully, but the illness can be very painful and debilitating, particularly due to joint symptoms
    The main risk is long‑lasting joint pain, rather than life‑threatening disease
    Short‑term risks (during the acute illness)
    Most people develop symptoms suddenly, including:
    High fever
    Severe joint pain (often hands, wrists, ankles, feet)
    Muscle pain
    Headache
    Sensitivity to lights
    Rash
    These symptoms usually last 1–2 weeks, but joint pain can significantly limit movement and daily activities during this period

Prices

Per Dose £180
Doses per course 1
Price per course £180
Course Currently one vaccine only is required
Find your nearest clinic
Book an appointment
SIMPLE, FAST & EASY

How it Works

Book an appointment online

Attend your consultation

£20 consultation fee may apply. View T&Cs for more information.

Get your treatment

Frequently Asked Question

Chikungunya is endemic (regularly present) is many parts of Africa, South and Southeast Asia is high risk, however also well established in The Americas and Caribbean and has been found in Europe. In many regions the risk is higher in the rainy season, check with your nurse or pharmacist if it is required.

 

The chikungunya Vimkuya vaccination is not suitable for: Children under the age of 12; Individuals not travelling to regions with active Chikungunya outbreaks; Individuals who have already had an anaphylactic reaction to a previous dose of a chikungunya vaccine, components of the vaccine or latex; Individual must not have moderate or severe acute illness (with or without fever); Individuals must consent to the service; The vaccination cannot be given to pregnant patients in their first trimester, and a risk assessment will be made for patients later in their pregnancy or breast feeding; Individuals with bleeding disorders or on anticoagulant therapy will be assessed for suitability. If you are offered the Ixchiq vaccine, this is suitable only for patients between the age of 12 – 60 years, and is not suitable for a person at any stage of pregnancy.

Trustpilot